Richiedi una copia del documento: Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT(1A) agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT(2A/2C) agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine

Captcha code
Annulla